Physician profile
Stanley Fox
NPI 1780673566
$310.45
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $41.38 · 2021: $77.35 · 2022: $32.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $62.76 | 2019 | |
| Allergan, INC. | $58.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.40 | 2020-2021 | |
| Abbvie INC. | $37.61 | 2021 | |
| Nevro Corp. | $32.87 | 2022 | |
| Esperion Therapeutics, INC. | $20.43 | 2020 | |
| Horizon Therapeutics Plc | $16.29 | 2021 | |
| Amgen INC. | $13.64 | 2019 | |
| Pfizer INC. | $12.47 | 2019 | |
| Seqirus USA INC | $11.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.